Triiodothyronine (T3) and 1,25-dihydroxyvitamin D3 (1,25D3) Inversely Regulate OPG Gene Expression in Dependence of the Osteoblastic Phenotype

Calcified Tissue International

Volumn 74, Issue 4, 2004, Pages 382-387

  Varga, F ^a   Spitzer, S ^a   Klaushofer, K ^a  

^a HANUSCH HOSPITAL   (Austria)

Author keywords

1,25 dihydroxyvitamin D3; Osteoblast; Osteocalcin; Osteoprotegerin; Triiodothyronine

Indexed keywords

CALCITRIOL; LIOTHYRONINE; MESSENGER RNA; OSTEOCALCIN; OSTEOPROTEGERIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BONE DEVELOPMENT; BONE MATRIX; BONE METABOLISM; CELL DIFFERENTIATION; GENE; GENE EXPRESSION; MINERALIZATION; MOUSE; NONHUMAN; OPG GENE; OSTEOBLAST; OSTEOCLAST; PHENOTYPE; PRIORITY JOURNAL; RNA TRANSCRIPTION;

3T3 CELLS; ANIMALS; BONE MARROW CELLS; CALCITRIOL; GENE EXPRESSION REGULATION; GLYCOPROTEINS; MICE; OSTEOBLASTS; OSTEOCALCIN; OSTEOPROTEGERIN; PHENOTYPE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STROMAL CELLS; TRIIODOTHYRONINE;

EID: 1842682960     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-003-0033-5     Document Type: Article

References (27)

1. Simonet WS, Lacey DL, Dunstan CR, et al. (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309-319
2. Tsuda E, Goto M, Mochizuki S, Yano K, Kobayashi F, Morinaga T, Higashio K (1997) Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun 234:137-142
3. Yasuda H, Shima N, Nakagawa N, et al. (1998) Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139: 1329-1337
4. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ (1999) Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20:345-357
5. Aubin JE, Bonnelye E (2000) Osteoprotegerin and its ligand; a new paradigm for regulation of osteoclastogenesis and bone resorption. Medscape Womens Health 5:5
6. Khosla S (2001) Minireview: the OPG/RANKL/RANK system. Endocrinology 142:5050-5055
7. Ducy P, Desbois C, Boyce B, et al. (1996) Increased bone formation in osteocalcin-deficient mice. Nature 382:448-452
8. Allain TJ, McGregor AM (1993) Thyroid hormones and bone. J Endocrinol 139:9-18
9. Mosekilde L, Eriksen EF, Charles P (1990) Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North Am 19:35-63
10. Kitazawa R, Kitazawa S, Maeda S (1999) Promoter structure of mouse RANKL/TRANCE/OPGL/ODF gene. Biochim Biophys Acta 1445:134-141
11. Nagai M, Sato N (1999) Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation. Biochem Biophys Res Commun 257:719-723
12. Thomas GP, Baker SU, Eisman JA, Gardiner EM (2001) Changing RANKL/OPG mRNA expression in differentiating murine primary osteoblasts. J Endocrinol 170:451-460
13. Gori F, Hofbauer LC, Dunstan CR, Spelsberg TC, Khosla S, Riggs BL (2000) The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated. Endocrinology 141:4768-4776
14. Varga F, Rumpler M, Luegmayr E, Fratzl-Zeeman N, Glantschnig H, Klaushofer K (1997) Triiodothyronine, a regulator of osteoblastic differentiation: depression of histone H4, attenuation of c-fos/c-jun, and induction of osteocalcin expression. Calcif Tissue Int 61:404-411
15. Fratzl-Zelman N, Fratzl P, Hörandner H, Grabner B, Varga F, Ellinger A, Klaushofer K (1998) Matrix mineralization in MC3T3-E1 cell cultures initiated by beta-glycerophosphate pulse. Bone 23:511-520
16. Wang D, Christensen K, Chawla K, Xiao G, Krebsbach PH, Franceschi RT (1999) Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. J Bone Miner Res 14:893-903
17. Varga F, Spitzer S, Rumpler M, Klaushofer K (2003) 1,25-dihydroxyvitamin D3 inhibits thyroid hormone-induced osteocalcin expression in mouse osteoblast-like cells via a thyroid hormone response element. J Mol Endocrinol 30:49-57
18. Otsuka E, Yamaguchi A, Hirose S, Hagiwara H (1999) Characterization of osteoblastic differentiation of stromal cell line ST2 that is induced by ascorbic acid. Am J Physiol, pp C132-C138
19. Wilkinson M (1988) RNA isolation: a mini-prep method. Nucl Acid Res 16:10933
20. Celeste AJ, Rosen V, Buecker JL, Kriz R, Wang EA, Wozney JM (1986) Isolation of the human gene for bone gla protein utilizing mouse and rat cDNA clones. Embo J 5:1885-1890
21. Frendo JL, Xiao G, Fuchs S, Franceschi RT, Karsenty G, Ducy P (1998) Functional hierarchy between two OSE2 elements in the control of osteocalcin gene expression in vivo. J Biol Chem 273:30509-30516
22. Thirunavukkarasu K, Halladay DL, Miles RR, Yang X, Galvin RJ, Chandrasekhar S, Martin TJ, Onyia JE (2000) The osteoblast-specific transcription factor Cbfa1 contributes to the expression of osteoprotegerin, a potent inhibitor of osteoclast differentiation and function. J Biol Chem 275:25163-25172
23. Schräder M, Muller KM, Carlberg C (1994) Specificity and flexibility of vitamin D signaling. Modulation of the activation of natural vitamin D response elements by thyroid hormone. J Biol Chem 269:5501-5504
24. Raval-Pandya M, Freedman LP, Li H, Christakos S (1998) Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation. Mol Endocrinol 12:1367-1379
25. Zhang R, Ducy P, Karsenty G (1997) 1,25-dihydroxyvitamin D3 inhibits osteocalcin expression in mouse through an indirect mechanism. J Biol Chem 272:110-116
26. Klaushofer K, Hoffmann O, Czerwenka E, Konig U Koller K, Peterlik M (1989) Interferon gamma and calcitonin induce differential changes in cellular kinetics and morphology of osteoclasts in cultured neonatal mouse calvaria. J Bone Miner Res 4:585-606
27. Ikeda T, Utsuyama M, Hirokawa K (2001) Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones. J Bone Miner Res 16:1416-1425